PMID- 25791144
OWN - NLM
STAT- MEDLINE
DCOM- 20161215
LR  - 20181202
IS  - 1527-5418 (Electronic)
IS  - 0890-8567 (Linking)
VI  - 54
IP  - 4
DP  - 2015 Apr
TI  - Group therapy for adolescents with attention-deficit/hyperactivity disorder: a 
      randomized controlled trial.
PG  - 275-82
LID - S0890-8567(15)00036-2 [pii]
LID - 10.1016/j.jaac.2014.12.016 [doi]
AB  - OBJECTIVE: To determine the efficacy of group cognitive-behavioral therapy (CBT) 
      on adolescents with attention-deficit/hyperactivity disorder (ADHD) who were in 
      pharmacological treatment but still had persistent symptoms. METHOD: We conducted 
      a multicenter, randomized, rater-blinded, controlled trial between April 2012 and 
      May 2014 in a cohort of 119 adolescents (15-21 years of age). Participants were 
      randomly assigned to 12 manualized group CBT sessions (n = 45) or a waiting list 
      control group (n = 44). Primary outcomes were assessed by a blinded evaluator 
      (ADHD Rating Scale [ADHD-RS], Clinical Global Impression Scale for Severity 
      [CGI-S], Global Assessment of Functioning [GAF]) before and after treatment, as 
      well as by self-report and parent informant ratings. RESULTS: Of the initial 119 
      participants enrolled, 89 completed treatment. A mixed-effects model analysis 
      revealed that participants who were assigned to the group CBT sessions 
      experienced significantly reduced ADHD symptoms compared to the control group 
      (ADHD-RS Adolescent: -7.46, 95% CI = -9.56 to -5.36, p < .001, d = 7.5; ADHD-RS 
      Parents: -9.11, 95% CI = -11.48 to -6.75, p < .001, d = 8.38; CGI-S 
      Self-Report: -0.68, 95% CI = -0.98 to -0.39, p < .001, d = 3.75; CGI-S 
      Clinician: -0.79, 95% CI = -0.95 to -0.62, p < .001; d = 7.71). Functional 
      impairment decreased significantly in the CBT group according to parents (Weiss 
      Functional Impairment Scale -4.02, 95% CI = -7.76 to -0.29, p < .05, d = 2.29) 
      and according to the blinded evaluator (GAF: -7.58, 95% CI = -9.1 to -6.05, p < 
      .001, d = 7.51). CONCLUSION: Group CBT associated with pharmacological treatment 
      is an efficacious intervention for reducing ADHD symptoms and functional 
      impairment in adolescents. Clinical trial registration information-CBT Group for 
      Adolescents With ADHD: a Randomized Controlled Trial; http://clinicaltrials.gov/; 
      NCT02172183.
CI  - Copyright (c) 2015 American Academy of Child and Adolescent Psychiatry. Published 
      by Elsevier Inc. All rights reserved.
FAU - Vidal, Raquel
AU  - Vidal R
AD  - Hospital Universitari Vall d'Hebron, ADHD (Attention-Deficit/Hyperactivity 
      Disorder) Program, Centro de Investigacion Biomedica En Red de Salud Mental 
      (CIBERSAM), Barcelona, Spain, and Universitat Autonoma de Barcelona.
FAU - Castells, Jordi
AU  - Castells J
AD  - Hospital Clinic of Barcelona.
FAU - Richarte, Vanesa
AU  - Richarte V
AD  - Hospital Universitari Vall d'Hebron, ADHD Program, Barcelona, Spain.
FAU - Palomar, Gloria
AU  - Palomar G
AD  - Hospital Universitari Vall d'Hebron, ADHD Program, Barcelona, Spain.
FAU - Garcia, Marta
AU  - Garcia M
AD  - Hospital Clinic of Barcelona.
FAU - Nicolau, Rosa
AU  - Nicolau R
AD  - Hospital Clinic of Barcelona.
FAU - Lazaro, Luisa
AU  - Lazaro L
AD  - Hospital Clinic of Barcelona, (CIBERSAM), Institut d'Investigacions Biomediques 
      August Pi i Sunyer (IDIBAPS) and with the University of Barcelona.
FAU - Casas, Miguel
AU  - Casas M
AD  - Hospital Universitari Vall d'Hebron, ADHD (Attention-Deficit/Hyperactivity 
      Disorder) Program, Centro de Investigacion Biomedica En Red de Salud Mental 
      (CIBERSAM), Barcelona, Spain, and Universitat Autonoma de Barcelona.
FAU - Ramos-Quiroga, Josep Antoni
AU  - Ramos-Quiroga JA
AD  - Hospital Universitari Vall d'Hebron, ADHD (Attention-Deficit/Hyperactivity 
      Disorder) Program, Centro de Investigacion Biomedica En Red de Salud Mental 
      (CIBERSAM), Barcelona, Spain, and Universitat Autonoma de Barcelona. Electronic 
      address: jaramos@vhebron.net.
LA  - eng
SI  - ClinicalTrials.gov/NCT02172183
PT  - Journal Article
PT  - Multicenter Study
PT  - Randomized Controlled Trial
PT  - Research Support, Non-U.S. Gov't
DEP - 20150126
PL  - United States
TA  - J Am Acad Child Adolesc Psychiatry
JT  - Journal of the American Academy of Child and Adolescent Psychiatry
JID - 8704565
SB  - IM
CIN - Evid Based Ment Health. 2015 Nov;18(4):125. PMID: 26363039
EIN - J Am Acad Child Adolesc Psychiatry. 2017 Nov;56(11):1000-1001. PMID: 29096763
MH  - Adolescent
MH  - Adult
MH  - Attention Deficit Disorder with Hyperactivity/diagnosis/*therapy
MH  - Cognitive Behavioral Therapy/*methods
MH  - Female
MH  - Humans
MH  - Male
MH  - Psychiatric Status Rating Scales
MH  - Psychotherapy, Group/*methods
MH  - Self Report
MH  - Severity of Illness Index
MH  - Single-Blind Method
MH  - Spain
MH  - Treatment Outcome
MH  - Young Adult
OTO - NOTNLM
OT  - ADHD
OT  - cognitive-behavioral therapy
OT  - group therapy
OT  - psychological treatment
EDAT- 2015/03/21 06:00
MHDA- 2016/12/16 06:00
CRDT- 2015/03/21 06:00
PHST- 2014/06/24 00:00 [received]
PHST- 2014/12/15 00:00 [revised]
PHST- 2015/01/21 00:00 [accepted]
PHST- 2015/03/21 06:00 [entrez]
PHST- 2015/03/21 06:00 [pubmed]
PHST- 2016/12/16 06:00 [medline]
AID - S0890-8567(15)00036-2 [pii]
AID - 10.1016/j.jaac.2014.12.016 [doi]
PST - ppublish
SO  - J Am Acad Child Adolesc Psychiatry. 2015 Apr;54(4):275-82. doi: 
      10.1016/j.jaac.2014.12.016. Epub 2015 Jan 26.